Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805. Clin Cancer Res. 2005 Jun 01; 11(11):4176-81.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Drug Administration Schedule
Female
Flavonoids
Humans
Infusion Pumps
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Neutropenia
Piperidines
Survival Analysis
Thrombocytopenia
Treatment Outcome

authors with profiles

Olatoyosi Odenike
Richard A. Larson